Both in Pharmaceuticals
Allarity Therapeutics vs Kyntra Bio
Over the past year ALLR returned −5.0% and KYNB returned −54.6%; their daily moves had a correlation of -0.05.
ALLR −5.0% KYNB −54.6%Growth of $1, one year, split-adjusted
| Metric | ALLR | KYNB |
|---|---|---|
| Price | $1.13 | $4.31 |
| Market cap | $18.0M | $17.5M |
| Today | +15.58% | −3.36% |
| 1 month | +13.0% | −29.2% |
| 6 months | −19.3% | −39.3% |
| Year to date | +4.6% | — |
| 1 year | −22.1% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 52.1× | — |
| Net cash | -$5.3M | $91.3M |
| Dividend yield | — | — |
| Volatility (60d) | 74.9% | 55.1% |
| Short % of float | 1.1% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).